Akzo Nobel N.V.
AKZA.AS · AMS
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €10,711,000 | €10,668,000 | €10,846,000 | €9,587,000 |
| % Growth | 0.4% | -1.6% | 13.1% | – |
| Cost of Goods Sold | €6,374,000 | €6,434,000 | €6,923,000 | €5,732,000 |
| Gross Profit | €4,337,000 | €4,234,000 | €3,923,000 | €3,855,000 |
| % Margin | 40.5% | 39.7% | 36.2% | 40.2% |
| R&D Expenses | €296,000 | €270,000 | €258,000 | €230,000 |
| G&A Expenses | €323,000 | €328,000 | €338,000 | €276,000 |
| SG&A Expenses | €1,563,000 | €1,538,000 | €1,531,000 | €1,296,000 |
| Sales & Mktg Exp. | €1,240,000 | €1,210,000 | €1,193,000 | €1,020,000 |
| Other Operating Expenses | €1,561,000 | -€27,000 | €1,426,000 | €1,211,000 |
| Operating Expenses | €3,420,000 | €3,205,000 | €3,215,000 | €2,737,000 |
| Operating Income | €917,000 | €1,029,000 | €708,000 | €1,118,000 |
| % Margin | 8.6% | 9.6% | 6.5% | 11.7% |
| Other Income/Exp. Net | -€79,000 | -€245,000 | -€106,000 | -€13,000 |
| Pre-Tax Income | €838,000 | €784,000 | €602,000 | €1,105,000 |
| Tax Expense | €246,000 | €296,000 | €214,000 | €246,000 |
| Net Income | €542,000 | €442,000 | €352,000 | €829,000 |
| % Margin | 5.1% | 4.1% | 3.2% | 8.6% |
| EPS | 3.17 | 2.59 | 2.01 | 4.48 |
| % Growth | 22.4% | 28.9% | -55.1% | – |
| EPS Diluted | 3.16 | 2.58 | 2.01 | 4.46 |
| Weighted Avg Shares Out | 170,729 | 170,600 | 174,735 | 184,960 |
| Weighted Avg Shares Out Dil | 171,519 | 171,339 | 175,313 | 185,874 |
| Supplemental Information | – | – | – | – |
| Interest Income | €88,000 | €102,000 | €29,000 | €12,000 |
| Interest Expense | €190,000 | €272,000 | €106,000 | €74,000 |
| Depreciation & Amortization | €371,000 | €355,000 | €362,000 | €351,000 |
| EBITDA | €1,399,000 | €1,413,000 | €1,052,000 | €1,530,000 |
| % Margin | 13.1% | 13.2% | 9.7% | 16% |